
Izvēlieties etiķeti
redzama tieši uz flakonaBPC + TB + KPV Blend
Healing
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
Īsumā
BPC + TB + KPV Blend skaitļos
Galvenie rādītāji no mūsu leksikona.
Pilns leksikona ieraksts- Class
- Healing blendBPC + TB + KPV
- Use
- Subcutaneousin mg, a third each
- Sizes
- 30 mg1 size in the shop
What studies show
The source in the lexicon- Dalmasso et al., Gastroenterology, 2008
Produktam BPC + TB + KPV Blend vēl nav laboratorijas analīzes. Balsot par toPasūtiet testu, mēs apmaksājam pusiVisas laboratorijas analīzes
Zināšanas
Viss par BPC + TB + KPV Blend
Detalizēta informācija drīzumā.
Dozēšana
Ielādē dozēšanas informāciju …
Noderēs
Kas jums vēl būs vajadzīgs
Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.
Insulīna šļirces
10 gab. · 5.50 €
Spirta salvetes
50 gab. · 10 €
Cik daudz ūdens?
Vienības uz šļirces jūsu flakona izmēram.
Atvērt kalkulatoru →Are there studies on this blend?
No. As of 26 October 2026 ClinicalTrials.gov lists no trial with KPV and none with two of the three components together. Everything here comes from studies on the single compounds.
What is KPV supposed to add to the blend?
KPV is the last three building blocks of alpha-MSH. The transporter PepT1 carries it into gut and immune cells, where it inhibits the NF-κB and MAP kinase pathways even at nanomolar amounts. In colitis models in mice KPV in the drinking water reduced inflammation, also in animals without a functional MC1R. Whether it adds anything when injected together with BPC-157 and TB-500 has not been tested.
Do BPC-157 and TB-500 work better together?
That is not established. In 32 rats with a repaired Achilles tendon each on its own was linked to better tendon tissue, above all TB-500. The combination gave no advantage over either alone. KPV was not part of this study.
What do the studies on the single components show?
With KPV drops all 8 corneal wounds closed in rabbits within 60 hours, none with placebo. Thymosin beta-4 sped up wound closure in rats by up to 61 percent. BPC-157 promoted new blood vessels via the receptor VEGFR2. All animal and cell studies.
Which human studies exist?
None on KPV. For BPC-157 three small studies with 30 people in total, all without a control group, plus a planned phase 1 trial. Thymosin beta-4 was tested into a vein in healthy adults and in phase 2 after heart attack.
Which side effects are known?
None for the blend. The three human studies on BPC-157 saw no treatment-related side effects, with very low certainty. 40 healthy people tolerated thymosin beta-4 into a vein without serious side effects. For KPV human data are missing entirely.
Saistītie
Saistītie produkti
BPC-157
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
4 izmēri
Laboratorijā pārbaudīts
= no 5.2 €/flakons
TB-500 (Thymosin B4)
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
3 izmēri
Laboratorijā pārbaudīts
= no 18.8 €/flakons
TB-500 FRAG
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
1 izmērs
= 24.8 €/flakons
BPC + TB Blend
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
3 izmēri
Laboratorijā pārbaudīts
= no 24.8 €/flakons
BPC + TB + KPV Blend